<DOC>
	<DOCNO>NCT00131768</DOCNO>
	<brief_summary>This clinical study evaluate safety efficacy Synvisc patient symptomatic ankle osteoarthritis ( OA ) . Patients give Synvisc , possible administration second injection insufficient symptomatic pain relief experience initial 3 month follow period .</brief_summary>
	<brief_title>A Study Safety Efficacy Synvisc Patients With Symptomatic Ankle Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Patients symptomatic OA pain ankle ( talocrural ) Patients current prior condition treatment would impede measurement efficacy safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>osteoarthritis ankle</keyword>
	<keyword>musculoskeletal</keyword>
</DOC>